FDA Releases Revised Draft Guidance on Labeling of Nonprescription Human Drugs

Summary

The Food and Drug Administration (FDA) has released a revised draft guidance to help the pharmaceutical industry comply with labeling requirements for nonprescription human drugs marketed without FDA approval. The revised guidance changes the enforcement date for these requirements.